More about

Memorial Sloan Kettering Cancer Center

News
March 23, 2023
3 min read
Save

Zolbetuximab regimen extends survival in gastric, gastroesophageal junction cancer subset

Zolbetuximab regimen extends survival in gastric, gastroesophageal junction cancer subset

The addition of zolbetuximab to capecitabine and oxaliplatin significantly extended PFS and OS for patients with claudin-18.2-positive/HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction cancer.

News
March 19, 2023
1 min read
Save

American Society for Transplantation and Cellular Therapy names president

American Society for Transplantation and Cellular Therapy names president

Miguel-Angel Perales, MD, has been named president of American Society for Transplantation and Cellular Therapy for 2023-2024.

News
February 24, 2023
3 min read
Save

Iomab-B may increase transplant access, improve outcomes in relapsed/refractory AML

Iomab-B may increase transplant access, improve outcomes in relapsed/refractory AML

Targeted conditioning with iodine (131I) apamistamab enabled older patients with relapsed or refractory acute myeloid leukemia to undergo allogeneic hematopoietic stem cell transplantation, according to results of the phase 3 SIERRA trial.

News
February 22, 2023
10 min read
Save

‘Exciting’ research spotlights CAR-T’s evolving role in blood cancer treatment

‘Exciting’ research spotlights CAR-T’s evolving role in blood cancer treatment

Only a decade ago, many in oncology considered chimeric antigen receptor T-cell therapy too fringe for real-world use.

News
February 20, 2023
4 min read
Save

Clear, inclusive messaging crucial to recruit LGBTQ+ stem cell donors

Clear, inclusive messaging crucial to recruit LGBTQ+ stem cell donors

Although gay, bisexual and other men who have sex with men can serve as volunteer unrelated stem cell donors for people in need of transplants, they have long faced exclusion from donation and represent a largely untapped donor pool.

News
February 13, 2023
3 min read
Save

New COVID-19 variants have ‘major impact’ on prevention for cancer cell therapy recipients

New COVID-19 variants have ‘major impact’ on prevention for cancer cell therapy recipients

The FDA recently withdrew its emergency use authorization for Evusheld, a combination monoclonal antibody therapy used to prevent COVID-19 among high-risk individuals.

News
February 10, 2023
3 min read
Save

ODAC: Single-arm trial data will suffice for dostarlimab in rectal cancer subgroup

ODAC: Single-arm trial data will suffice for dostarlimab in rectal cancer subgroup

Data from a pair of single-arm clinical trials will be sufficient to illustrate the benefits and risks of dostarlimab-gxly for a subgroup of patients with rectal cancer, according to the FDA’s Oncologic Drugs Advisory Committee.

News
January 25, 2023
9 min read
Save

NCI-funded centers study new ways to apply telehealth across cancer care

NCI-funded centers study new ways to apply telehealth across cancer care

Nearly 3 years after the COVID-19 pandemic propelled telehealth from the fringes of cancer care to the mainstream, research into the use of this technology across oncology remains limited.

News
January 24, 2023
2 min read
Save

Long-course chemoradiation may improve organ preservation rates in rectal cancer

Long-course chemoradiation may improve organ preservation rates in rectal cancer

A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal cancer, according to a study presented at ASCO Gastrointestinal Cancers Symposium.

News
January 23, 2023
2 min read
Save

Plant-based diet may improve outcomes for patients with multiple myeloma

Plant-based diet may improve outcomes for patients with multiple myeloma

A plant-based diet appeared associated with sustained minimal residual disease negativity among a cohort of patients with multiple myeloma, according to study results.

View more